Role of common fragile sites and corresponding genes in cancer development

Cellular and Molecular Life Sciences

Volumn 71, Issue 23, 2014, Pages 4487-4488

  Aqeilan, Rami I ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Common fragile sites; FHIT; Genomic instability; Large genes; Replication fork; Replication stress; Tumor suppressor; WWOX

Indexed keywords

APHIDICOLIN; PEPTIDES AND PROTEINS; PROTEIN WWOX; UNCLASSIFIED DRUG; ACID ANHYDRIDE HYDROLASE; FRAGILE HISTIDINE TRIAD PROTEIN; OXIDOREDUCTASE; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN; WWOX PROTEIN, HUMAN;

CANCER INHIBITION; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMATIN; CHROMOSOME BREAKAGE; CHROMOSOME FRAGILE SITE; COMMON CHROMOSOME FRAGILE SITE; DNA DAMAGE; DNA REPLICATION; EPIGENETICS; FHIT GENE; GENETIC TRANSCRIPTION; GENOMIC INSTABILITY; HUMAN; REVIEW; TUMOR GENE; TUMOR SUPPRESSOR GENE; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; NEOPLASM;

ACID ANHYDRIDE HYDROLASES; ANIMALS; CHROMOSOME FRAGILE SITES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMIC INSTABILITY; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; OXIDOREDUCTASES; TUMOR SUPPRESSOR PROTEINS;

EID: 84922074882     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-014-1716-y     Document Type: Review

References (11)

1. Dekaban A (1965) Persisting clone of cells with an abnormal chromosome in a woman previously irradiated. J Nucl Med 6(10):740-746
2. Glover TW, Berger C, Coyle J, Echo B (1984) DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum Genet 67(2):136-142
3. Durkin SG, Glover TW (2007) Chromosome fragile sites. Annu Rev Genet 41:169-192
4. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646-674
5. Negrini S, Gorgoulis VG, Halazonetis TD (2010) Genomic instability - an evolving hallmark of cancer. Nat Rev Mol Cell Biol 11(3):220-228
6. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, McHenry KT, Pinchback RM, Ligon AH, Cho YJ, Haery L, Greulich H et al (2010) The landscape of somatic copy-number alteration across human cancers. Nature 463(7283):899-905
7. Bignell GR, Greenman CD, Davies H, Butler AP, Edkins S, Andrews JM, Buck G, Chen L, Beare D, Latimer C, Widaa S, Hinton J, Fahey C, Fu B, Swamy S, Dalgliesh GL et al (2010) Signatures of mutation and selection in the cancer genome. Nature 463(7283):893-898
8. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C, Orntoft T, Lukas J, Bartek J (2005) DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434(7035):864-870
9. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, Venere M, Ditullio RA Jr, Kastrinakis NG, Levy B, Kletsas D, Yoneta A, Herlyn M, Kittas C, Halazonetis TD (2005) Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434(7035):907-913
10. Dereli-Oz A, Versini G, Halazonetis TD (2011) Studies of genomic copy number changes in human cancers reveal signatures of DNA replication stress. Mol Oncol 5(4):308-314
11. Halazonetis TD, Gorgoulis VG, Bartek J (2008) An oncogene-induced DNA damage model for cancer development. Science 319(5868):1352-1355